Physician

Tracie Watson, D.O.

According to 2025 Medicare claims, Tracie Watson, D.O. (NPI: 1275875965) practices hematology/oncology in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Contra Costa, CA. This provider's primary affiliated billing organization is MICHAEL P SHERMAN MD PHD, A MEDICAL CORPORATION (NPI: 1831201912; TIN: 202298787) and primary practice location at 94598-2415.

Watson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 235 traditional Medicare patients, billed 97,161 HCPCS/CPT codes, and received $1,485,169 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 429 prescription claims across 59 beneficiaries totaling $2,081,291 in drug costs, led by Brukinsa (Zanubrutinib). Open Payments data shows 62 records totaling $1,545. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $3,382 to $2,081,291. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$743K$1.5M2021 Medicare payment: $119,669 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $367,186 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $752,901 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,485,169 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021909,582$119,669
202216440,380$367,186
202322281,767$752,901
202423597,161$1,485,169

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.0M$2.1M2015 Drug cost: $3,382 (USD; Tot_Drug_Cst)2016 Drug cost: $5,297 (USD; Tot_Drug_Cst)2017 Drug cost: $3,307 (USD; Tot_Drug_Cst)2018 Drug cost: $151 (USD; Tot_Drug_Cst)2019 Drug cost: $50,811 (USD; Tot_Drug_Cst)2021 Drug cost: $26,270 (USD; Tot_Drug_Cst)2022 Drug cost: $182,405 (USD; Tot_Drug_Cst)2023 Drug cost: $1,621,755 (USD; Tot_Drug_Cst)2024 Drug cost: $2,081,291 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151249$3,382
201622105$5,297
20171369$3,307
2018N/R11$151
2019N/R13$50,811
2020N/RN/RN/R
20212165$26,270
20222557$182,405
202349266$1,621,755
202459429$2,081,291

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more48240$168
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes7484$153
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more97343$114
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes74166$105
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more85130$82

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BrukinsaZanubrutinib24720$349,960
Darzalex FasproDaratumumab-Hyaluronidase-Fihj35317$340,972
TagrissoOsimertinib Mesylate12360$203,938
CalquenceAcalabrutinib Maleate13390$190,190
PromactaEltrombopag Olamine13390$160,486

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.62$1,545PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Tracie Watson, D.O.?

Tedicare shows public-source Medicare data for Tracie Watson, D.O. (NPI 1275875965), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tracie Watson, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tracie Watson, D.O.?

Tracie Watson, D.O. is linked to MICHAEL P SHERMAN MD PHD, A MEDICAL CORPORATION (billing NPI 1831201912) in the available physician profile data.

Does Tracie Watson, D.O. have Open Payments data?

Tracie Watson, D.O. has 62 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.